Till now the company was focused on international markets

Medicamen Biotech announces debut in domestic pharma sector

Uniphos Enterprises Ltd, Shivalik Rasayan Ltd, Medicamen Biotech Ltd and Peninsula Land Ltd are among the other gainers in the BSE’s ‘B’ group today, 26 August 2022.

Aarvee Denims & Exports Ltd leads gainers in ‘B’ group

Vital Pharma Nordic is led by highly experienced specialists and engaged in licensing, development, distribution and sales of specialty Gx pharmaceuticals. VPN operate in the Nordic region now expanding internationally.

Medicamen Biotech signs CDMO agreement with Vital Pharma Nordic

The company had signed an agreement with the Tirupati Reality & Developers on October 14, 2020.

Medi Caps gets approval under RERA for Real Estate Project ‘Medicaps Business Park’

Medicamen Biotech hit a new high of Rs 948.95, having rallied 13 per cent on the BSE in Thursday’s intra-day deal.

This smallcap pharmaceutical stock has zoomed 62% thus far in December

AksharChem (India) Ltd, DE Nora India Ltd, Zee Learn Ltd and Medicamen Biotech Ltd are among the other gainers in the BSE’s ‘B’ group today, 03 December 2021.

Starlit Power Systems Ltd leads gainers in ‘B’ group

Medicamen Biotech consolidated net profit rises 31.06% in the September 2021 quarter

Medicamen Biotech standalone net profit rises 31.06% in the September 2021 quarter

Medi Caps consolidated net profit rises 58.77% in the June 2021 quarter

Medi Caps reports standalone net loss of Rs 0.05 crore in the June 2021 quarter

Medicamen Biotech consolidated net profit rises 46.59% in the March 2021 quarter

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

MEDICAMEN Biotech is engaged in manufacturing of pharmaceutical formulations.